Patients on Antithrombotics for Colonoscopy
The use of antithrombotics (antiplatelet agents and anticoagulants) is increasing with an aging global population.Management of antithrombotics in patients undergoing invasive procedures including gastrointestinal endoscopy remains a challenge. Management approach includes taking a precarious balance between the risk o
| Condition(s) | Antithrombotics, Colonoscopy |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The use of antithrombotics (antiplatelet agents and anticoagulants) is increasing with an aging global population.Management of antithrombotics in patients undergoing invasive procedures including gastrointestinal endoscopy remains a challenge. Management approach includes taking a precarious balance between the risk of thromboembolism after interruption of antithrombotics and risk of bleeding with the continuation of antithrombotics. Colonoscopy remains one of the commonest endoscopic procedures performed. The optimal management strategy of different antithrombotics during colonoscopy remains unclear. |
| Who can participate | Inclusion Criteria: * Patients must be over 18 years of age * Patients undergoing elective colonoscopy for any indication, who are receiving antithrombotics * Informed consent is obtained Exclusion Criteria: * Patients under 18 years of age * Inability to give informed consent |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Chinese University of Hong Kong |
| Locations | Hong Kong, Hong Kong |
| Start date | 2017-12-08 |
| NCT ID | NCT03363061 |
| Official listing | https://clinicaltrials.gov/study/NCT03363061 |